Targeting the HLA-E–NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG by Yuxuan Deng, Jinqiu Liu, Zhuonan Pu, Yi Wang, Tian Li, Zhuang Jiang, Luyang Xie, Xiaoli Zhang, YingDan Chen, Mingxu Yang, Chao Du, Shuyu Hao, Nan Ji, Zhengping Zhuang, Jie Feng, Liwei Zhang

Get full text